Dr Carl A Power

Head of BRIL

Category: Academic Staff
Research profile: Click to view


As head of BRIL, Dr Power has diverse interests in Preclinical imaging techniques including MRI, PET, CT, Optical Imaging and Ultrasound.

In the area of cancer biology in general and specifically prostate cancer biology, research is focused on use of animal models to identify mechanisms of prostate cancer metastasis to bone, immune responses to prostate cancer and its bone metastases and preclinical assessment of treatments to prevent bone mets.


Book Chapters

Xiao WW;Graham P;Power C;Li Y, 2011, 'Biomarkers for radiosensitivity and radiosensitization targets in prostate cancer', in Tumor Suppressors, pp. 189 - 228

Conference Papers

Mattner F;Hung T-T;Bourdier T;Lee B;Henderson D;Poon J;Doan J;Power C;Katsifis A;Fulham M, 2015, 'Evaluation of F-18-TSPO radiotracers in a prostate tumour model using PET', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, Baltimore, MD, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging, Baltimore, MD, 06 - 10 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358738801206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
View more
Reilhac A;Nezich R;Price R;Besmer A;Sunn N;Power C;Zahra D;Hamze H;Boisson F;Gregoire M-C, 2014, 'IMAGE-QUALITY ASSESSMENT OF SEVERAL POSITRON EMITTERS FOR PRECLINICAL IMAGING', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 33 - 33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334282000098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Hung TT;Russell PJ;Power C, 2010, 'Circulating and tumour-infiltrating CD4+IL-17+ T-cells in mice bearing orthotopic and heterotopic prostate tumours', in Proceedings of the American Association for Cancer Research, American Association Cancer Research, Walter E.Washington Convention Centre, Washington DC, pp. 1162 - 1162, presented at AACR 101st Annual Meeting, Walter E.Washington Convention Centre, Washington DC, 17 - 21 April 2010
Power C;Cho J;Pwint H;Hung TT;Russell PJ, 2009, 'Combined Docetaxel and Zoledronic Acid Treatment for Bone Metastatic Murine Prostate Cancer.', in Cancer & Bone Society, VIIIth International Meeting on Cancer Induced Bone Disease, Sydney, presented at VIIIth International Meeting on Cancer Induced Bone Disease, Sydney, 25 - 26 March 2009
Li Y;Wang J;Rizvi SM A;Cozzi PJ;Madigan MC;Power CA;Russell PJ;Allen BJ, 2006, 'Control of DU 145 and LNCaP-LN3 prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Amsterdam, NETHERLANDS, pp. 47 - 47, presented at 4th International Symposium on Targeted Anticancer Therapies, Amsterdam, NETHERLANDS, 16 - 18 March 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237800900090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Fazekas de St Groth B;Seddiki N;Tan S;Higgins C;Power C;Santner-Nanan B;Nanan R;Sasson S;Zaunders J;Kelleher A;Landay A, 2005, 'Regulatory T cells and the maintenance of tolerance', in TISSUE ANTIGENS, BLACKWELL PUBLISHING, Melbourne, AUSTRALIA, pp. 412 - 412, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne, AUSTRALIA, 29 November - 02 December 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700194&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Tse BW C;Russell PJ;Power CA, 2005, 'IL-18 expression inhibits growth of RM1 murine prostate carcinomas', in TISSUE ANTIGENS, BLACKWELL PUBLISHING, Melbourne, AUSTRALIA, pp. 568 - 568, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne, AUSTRALIA, 29 November - 02 December 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700616&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Hung TT;Power CA;Russell PJ, 2005, 'Inhibition of tumorigenicity of invasive human bladder cancer cells by a non-tumorigenic subline from the same xenograft: Identification of differentially expressed genes.', in CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, AMER ASSOC CANCER RESEARCH, Baltimore, MD, pp. 2742S - 2743S, presented at 4th Annual Conference on Frontiers in Cancer Prevention Research, Baltimore, MD, 30 October - 02 November 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233351200253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Journal articles

Rashid I;Maghzal GJ;Chen YC;Cheng D;Talib J;Newington D;Ren M;Vajandar SK;Searle A;Maluenda A;Lindstedt EL;Jabbour A;Kettle AJ;Bongers A;Power C;Michaëlsson E;Peter K;Stocker R, 2018, 'Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque', European Heart Journal, vol. 39, pp. 3301 - 3310, http://dx.doi.org/10.1093/eurheartj/ehy419
Menon J;Hoeppner VH;Judd A;Power CA;Bretscher PA, 2018, 'A hypothesis for the existence of two types of tuberculosis, reflecting two distinct types of immune failure to control the pathogen, based upon prevalence of mycobacterium-specific IgG subclasses', Scandinavian Journal of Immunology, vol. 87, http://dx.doi.org/10.1111/sji.12665
Norddin N;Power C;Watson G;Cowin G;Kurniawan ND;Gluch L;Bourne RM, 2015, 'Microscopic diffusion properties of fixed breast tissue: Preliminary findings', Magnetic Resonance in Medicine, vol. 74, pp. 1733 - 1739, http://dx.doi.org/10.1002/mrm.25555
Bolton HA;Zhu E;Terry AM;Guy TV;Koh WP;Tan SY;Power CA;Bertolino P;Lahl K;Sparwasser T;Shklovskaya E;Barbara BF, 2015, 'Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease', Journal of Clinical Investigation, vol. 125, pp. 3627 - 3641, http://dx.doi.org/10.1172/JCI76031
Tse BW C;Jovanovic L;Nelson CC;De Souza P;Power CA;Russell PJ, 2014, 'From Bench to Bedside: Immunotherapy for Prostate Cancer', BioMed Research International, vol. 2014, http://dx.doi.org/10.1155/2014/981434
Bourne R;Power C;Chatterjee A;Cowin G;Kurniawan N;Watson G, 2014, 'DISTINCTIVE WATER DIFFUSION PROPERTIES OF EPITHELIA MAY BE THE KEY TO BETTER CANCER IMAGING TECHNIQUES', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 10, pp. 24 - 24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Thibaudeau L;Taubenberger AV;Holzapfel BM;Quent VM;Fuehrmann T;Hesami P;Brown TD;Dalton PD;Power CA;Hollier BG;Hutmacher DW, 2014, 'A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone', DMM Disease Models and Mechanisms, vol. 7, pp. 299 - 309, http://dx.doi.org/10.1242/dmm.014076
Xiao W;Graham PH;Hao J;Chang L;Ni J;Power CA;Dong Q;Kearsley JH;Li Y, 2013, 'Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0074253
Ritchie HE;Ababneh DH;Oakes DJ;Power CA;Webster WS, 2013, 'The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo', Birth Defects Research Part B - Developmental and Reproductive Toxicology, vol. 98, pp. 144 - 153, http://dx.doi.org/10.1002/bdrb.21050
Holzapfel BM;Thibaudeau L;Hesami P;Taubenberger A;Holzapfel NP;Mayer-Wagner S;Power C;Clements J;Russell P;Hutmacher DW, 2013, 'Humanised xenograft models of bone metastasis revisited: Novel insights into species-specific mechanisms of cancer cell osteotropism', Cancer and Metastasis Reviews, vol. 32, pp. 129 - 145, http://dx.doi.org/10.1007/s10555-013-9437-5
Xiao W;Graham PH;Power CA;Hao J;Kearsley JH;Li Y, 2012, 'CD44 is a biomarker associated with human prostate cancer radiation sensitivity', Clinical and Experimental Metastasis, vol. 29, pp. 1 - 9, http://dx.doi.org/10.1007/s10585-011-9423-7
Hao J;Madigan MC;Khatri A;Power CA;Hung TT;Beretov J;Chang L;Xiao W;Cozzi PJ;Graham PH;Kearsley JH;Li Y, 2012, 'In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147', PLoS ONE, vol. 7, http://dx.doi.org/10.1371/journal.pone.0040716
Funnell AP W;Norton LJ;Mak KS;Burdach J;Artuz CM;Twine NA;Wilkins MR;Power CA;Hung TT;Perdomo J;Koh P;Bell-Anderson KS;Orkin SH;Fraser ST;Perkins AC;Pearson RC M;Crossley M, 2012, 'The CACCC-binding protein KLF3/BKLF represses a subset of KLF1/EKLF target genes and is required for proper erythroid maturation in vivo', Molecular and Cellular Biology, vol. 32, pp. 3281 - 3292, http://dx.doi.org/10.1128/MCB.00173-12
Hung TT;Chan J;Russell PJ;Power CA, 2011, 'Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model', PLoS ONE, vol. 6, http://dx.doi.org/10.1371/journal.pone.0019389
Tse BW C;Russell PJ;Lochner M;Förster I;Power CA, 2011, 'IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms', PLoS ONE, vol. 6, http://dx.doi.org/10.1371/journal.pone.0024241
Wang L;Chen H;Liu FH;Madigan MC;Power CA;Hao J;Patterson KI;Pourgholami MH;O'Brien PM;Perkins AC;Li Y, 2011, 'Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer', Cancer Letters, vol. 300, pp. 122 - 133, http://dx.doi.org/10.1016/j.canlet.2010.09.013
Hao JL;Cozzi PJ;Khatri A;Power CA;Li Y, 2010, 'CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer', Current Cancer Drug Targets, vol. 10, pp. 287 - 306, http://dx.doi.org/10.2174/156800910791190193
Power C;Marfleet TW;Qualtiere L;Xiao W;Bretscher P, 2010, 'Development of Th1 imprints to rBCG expressing a foreign protein: Implications for vaccination against HIV-1 and diverse influenza strains', Journal of Biomedicine and Biotechnology, vol. 2010, http://dx.doi.org/10.1155/2010/591348
Kiros T;Power C;Wei G;Bretscher P, 2010, 'Immunization of newborn and adult mice with low numbers of BCG leads to Th1 responses, Th1 imprints and enhanced protection upon BCG challenge', Immunotherapy, vol. 2, pp. 25 - 35
Li Y;Song E;Rizvi SM A;Power CA;Beretov J;Raja C;Cozzi PJ;Morgenstern A;Apostolidis C;Allen BJ;Russell PJ, 2009, 'Inhibition of micrometastatic prostate cancer cell spread in animal models by213bilabeled multipletargeted α radioimmunoconjugates', Clinical Cancer Research, vol. 15, pp. 865 - 875, http://dx.doi.org/10.1158/1078-0432.CCR-08-1203
Power CA;Pwint H;Chan J;Cho J;Yu Y;Walsh W;Russell PJ, 2009, 'A novel model of bone-metastatic prostate cancer in immunocompetent mice', Prostate, vol. 69, pp. 1613 - 1623, http://dx.doi.org/10.1002/pros.21010
Wang J;Rizvi SM A;Madigan MC;Cozzi PJ;Power CA;Qu CF;Morgenstern A;Apostolidis C;Russell PJ;Allen BJ;Li Y, 2006, 'Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted α radioimmunoconjugates', Prostate, vol. 66, pp. 1753 - 1767, http://dx.doi.org/10.1002/pros.20502
Power C, 2000, 'Factors that influence T helper cell response to infection', Current Opinion in Infectious Diseases, vol. 13, pp. 209 - 213
View less


Level 4, Lowy Cancer Research Centre (C25)


+61 2 9385 8655